查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830603

化合物管理市场（按最终用户、化合物类型、应用和自动化程度划分）—2025-2032 年全球预测

Compound Management Market by End User, Compound Type, Application, Automation Level - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，复合管理市场将成长至 44.5 亿美元，复合年增长率为 17.27%。

主要市场统计数据
基准年2024年 12.4亿美元
预计2025年 14.5亿美元
预测年份：2032年 44.5亿美元
复合年增长率（%） 17.27%

简明框架描述不断发展的化合物管理格局，强调重塑实验室工作流程的技术、材料和营运压力

化合物管理处于高通量科学、精准处理和日益复杂的供应链动态的交汇点。自动化、样品完整性监测和数位化库存管理领域的最新技术进步正在重新定义科学研究和商业性研发领域对精度、速度和可追溯性的期望。同时，治疗模式向生技药品、细胞和基因疗法的转变也带来了新的物料输送要求，这对传统平台提出了挑战，并需要专门定制的解决方案。

因此，领导者必须协调对稳健合规的化合物储存的需求与提高吞吐量和降低营运风险的压力。本介绍将重塑化合物管理的各种力量统一起来，明确价值创造的领域，并组装组织领导者应优先考虑的策略问题。建立通用的基准，使决策者能够更自信地评估技术投资、伙伴关係和流程重新设计，从而使化合物处理能力与更广泛的科学和监管目标保持一致。

自动化、生技药品复杂性和数据主导的互通性如何将化合物管理重新定义为一项策略性实验室能力

在科技趋势融合的推动下，化合物管理格局正经历一场变革。自动化正在超越机械化，发展成为整合式工作流程，其中机器人、环境控制和实验室资讯管理系统协同工作，形成一个整体。这种整合实现了可扩展的样本通量，同时减少了人工接触点和错误率。同时，复杂生技药品、基因疗法和细胞产品的兴起，对储存、处理和可追溯性提出了新的要求，而传统的小分子专用系统无法满足这些要求。

同时，以数据为中心的方法正在改变组织管理化合物库存的方式。进阶分析和预测性维护可以提高运作并减少试剂浪费，而数位审核追踪则可以增强法规遵循。此外，仪器製造商和软体供应商之间的合作正在加速实验室采用模组化、可升级系统的步伐。总而言之，这些转变意味着化合物管理不再是一项后勤部门功能，而是一项支援更快、更安全、更具成本效益的研究流程的策略能力。

营运和采购对关税变化的反应正在重塑供应商策略、库存实践和国际实验室合作

2025 年的关税变化给采购、合约营运和跨境研究合作带来了特殊压力。某些检测设备、耗材和化学品的进口关税上调，促使许多组织重新评估其供应商组合併重新协商合同，以保持营运的连续性。因此，采购团队正在与科学研究主管更紧密地合作，确定关键物资的优先储备，考虑替代供应商，并对区域代理商进行认证，以减少单一来源的风险。

在营运层面，一些实验室正在调整维护和校准计划，以优化现有设备的生命週期，避免在进口成本上涨期间即时更换设备。此外，他们更重视关键物资的国内生产，并建立试剂和耗材的策略性库存缓衝。由于海关分类和合规性检查，国际合作的前置作业时间更长，行政负担也更重。为此，研究机构正在加强供应链管治，增强需求预测实践，并寻求在买方和供应商之间共用关税风险的合约条款，以保持研究的连续性。

深度细分主导的洞察，揭示最终用户、化合物类型、应用和自动化程度之间的不同需求，以指导策略性产品和服务的协调

细分洞察揭示了差异化需求和采用模式，这些需求和模式指南产品开发、服务模式和市场开发方法。从最终用户的观点，学术和研究机构通常优先考虑灵活性、成本效益以及与多样化设备的开放式整合；而製药公司则寻求检验的可扩展系统，该系统具有严格的合规能力和长期服务协议；生物技术公司通常寻求能够适应计划范围快速变化的模组化解决方案；而受託研究机构专注于高水准和监管工作，以适应工程范围快速变化的模组化解决方案；

小分子通常受益于成熟的高密度储存和自动搜寻系统，而生技药品则需要专门的温度控制和污染预防。在生技药品领域，细胞治疗产品、基因治疗产品、单株抗体、重组蛋白和疫苗各自具有独特的处理和监管要求，这些要求会影响容器格式、低温运输通讯协定和检验途径。基于应用的细分錶明，农业化学品和材料科学等使用案例与药物研发活动具有不同的吞吐量和环境耐受性要求。在药物研发领域，诸如命中化合物识别、先导化合物优化、临床前研究和标靶验证等不同的工作流程对采样节奏、等分试样大小和完整性监测需求有特定的要求。选择全自动系统的组织会投资于端到端的数位化工作流程，并且需要更高的初始投资才能达到长期效率。同时，当灵活性、低资本支出或独特的样品类型阻碍了全自动系统时，手动和半自动化系统仍然很受欢迎。了解这些相互交叉的细分市场，可以帮助供应商和使用者根据实际营运需求调整解决方案的功能、服务水准和定价策略。

区域科学生态系统和法规环境如何影响全球市场的化合物管理重点、支援模型和自动化采用

区域动态决定了化合物管理投资、伙伴关係和营运弹性的优先顺序。美洲集中了大型製药研发中心和成熟的生物技术生态系统，推动了对高通量、检验的系统和服务模式的需求，以支持监管发展。该地区还拥有蓬勃发展的综合服务和本地化支援网路售后市场，鼓励供应商提供长期服务协议和客製化选项。欧洲、中东和非洲呈现出多元化的格局，跨国公司与国家研究机构和新兴生物技术部门并肩作战。欧洲部分地区的监管协调与其他地区针对特定区域的采购规则形成鲜明对比，这正在塑造自动化和先进库存系统的采用曲线。平衡跨境合作与当地监管限制的需求，导致该地区对合规的模组化解决方案产生了浓厚的兴趣。

亚太地区的特点是产能扩张迅速，对转化和临床研究投入巨大，并且生物技术新兴企业需要灵活且可扩展的化合物管理解决方案。该地区的供应链覆盖也促进了製造和零件采购机会，从而可以缩短某些设备的前置作业时间。在整个地区，人事费用、监管复杂性和基础设施成熟度的差异会影响全自动、半自动化或手动方法之间的选择，从而为提供差异化服务创造了机会，例如远距离诊断、区域备件库存和区域验证支援。

竞争动态和伙伴关係趋势揭示了硬体、软体和服务整合以及以应用为中心的创新如何塑造供应商差异化和客户维繫

竞争考察重点在于策略定位、伙伴关係模式以及日益凸显竞争差异化的领域。市场领导若能将强大的硬体产品组合与扩充性的软体平台和成熟的服务产品结合，最有可能赢得需要长期检验和保证运作的企业级专案。相反，新兴供应商将透过提供模组化、可升级的架构来降低中型实验室实现自动化的门槛，并透过开放API强调互通性，从而促进与实验室资讯管理系统的集成，从而获得发展动力。随着企业寻求提供涵盖安装、检验、维护和资料管理的端到端价值提案，仪器製造商、软体供应商和第三方服务机构之间的策略伙伴关係正变得越来越普遍。

此外，一些公司正在投资特定应用的解决方案，以满足生技药品、细胞和基因疗法的独特需求，例如温控物流和污染控制创新。差异化服务也值得关注：能够提供快速现场支援、透过物联网感测器进行远端预测性维护以及为内部技术人员提供客製化培训的供应商往往能够减少停机时间并增强客户维繫。最后，那些透过节能储存系统和减少消耗品的措施展现永续性承诺的公司，正在与寻求实现环境和管治目标的机构投资者产生共鸣。

为高阶主管提供可行的策略重点，以增强其复合管理环境中的互通性、供应弹性和数据主导的营运

产业领导者应采取果断行动，将化合物管理能力与科学策略和营运弹性结合。首先，高阶主管在互通性，管治合格倡议试剂利用率，从而同时提高吞吐量并降低营运风险。

此外，领导者应透过情境规划来评估其供应商和服务合约组合，其中应考虑区域采购差异和潜在的政策变化。投资员工培训和内部验证能力可以减少对外部服务供应商的依赖，并加快实验时间。最后，永续性和合规性应被定位为策略要务。采用节能储存技术，尽可能减少一次性塑胶的消费量，并记录监管链，可以缓解长期成本压力，并使组织与不断变化的相关人员期望保持一致。

采用严格的混合方法，结合实务工作者访谈、技术文献综述和专家检验，得出实用的商业见解和策略建议

本执行摘要所依据的调查方法是将一手资料和二手资料结构化地结合起来，并经过专家检验以确保其有效性和实用性。一手资料包括对学术机构、生物技术、合约研究、政府机构和製药公司的实验室经理、采购主管和技术总监的访谈，以获得第一手资料，了解他们的营运挑战和采购行为。二手资料包括供应商技术文献、监管指南文件、说明小分子和复杂生技药品不断变化的处理要求的同行评审出版物，以及关于自动化和数据集成最佳实践的白皮书。

这些输入资讯采用主题分析法进行综合，以识别反覆出现的痛点、应用推动因素和价值槓桿。与经验丰富的技术人员和供应链专业人员进行交叉检验，确保营运建议基于现实世界的限制和机会。我们谨慎地将敏感贡献者资讯匿名化，所有结论均侧重于定性趋势和可操作的洞察，而非定量的市场估计，使领导者能够将研究结果直接应用于技术选择、流程重新设计和供应商谈判。

全面、前瞻性的演示，解释为什么化合物管理是研发组织研究速度、样品完整性和法规遵循的策略推动因素

总而言之，化合物管理已从后勤部门功能演变为策略功能，对研究速度、资料完整性和法规遵循有重大影响。自动化程度的提高、生技药品、细胞和基因疗法日益重要，以及数据驱动的维护和库存管理日益重要，正在推动系统互通性、环境控制和服务可靠性的更高标准。积极在采购、科研营运和IT职能部门进行协作的组织将更有能力利用现代化合物管理系统带来的生产力提升，并降低与供应链波动和监管审查相关的风险。

展望未来，决策者应将化合物管理视为其研究平台策略的重要组成部分，在必要时投资模组化、检验的系统，加强供应商和区域风险管理，并利用分析技术优化运作和试剂使用。这样做将使实验室和开发机构能够提高通量，保护样品完整性，并支持推动科学和商业性成功的转化目标。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 透过人工智慧驱动的调度和预测路由集成，实现复合储存搜寻工作流程的自动化
  • 采用机器人纳升液体处理系统实现高密度化合物库管理
  • 在分散的化合物存储库中实施基于区块链的监管链跟踪
  • 引入支援物联网的温度和湿度感测器，用于即时化合物稳定性监测
  • 利用数位双胞胎模拟优化冷冻库除霜循环和化合物管理中的样品完整性
  • 化学品管理设施向永续无溶剂清洁和低温储存方法过渡

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章：化合物管理市场（依最终用户划分）

  • 学术研究机构
  • 生技公司
  • 合约研究组织
  • 政府和监管机构
  • 製药公司

9. 化合物管理市场（依化合物类型）

  • 生物製药
    • 细胞治疗产品
    • 基因治疗产品
    • 单株抗体
    • 重组蛋白
    • 疫苗
  • 核苷酸
  • 胜肽
  • 小分子

第 10 章化合物管理市场：依应用

  • 杀虫剂
  • 药物研发
    • 命中识别
    • 先导药物最适化
    • 临床前研究
    • 目标检验
  • 材料科学
  • 特种化学品

第 11 章 复合管理市场（依自动化程度）

  • 全自动系统
  • 手动系统
  • 半自动系统

第十二章化合物管理市场：按地区

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 化合物管理市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国化合物管理市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Tecan Group Ltd.
    • Hamilton Bonaduz AG
    • Brooks Automation, Inc.
    • Chemspeed Technologies GmbH
    • Hudson Robotics, Inc.
    • Analytik Jena AG
Product Code: MRR-436BDB26AFD9

The Compound Management Market is projected to grow by USD 4.45 billion at a CAGR of 17.27% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.24 billion
Estimated Year [2025] USD 1.45 billion
Forecast Year [2032] USD 4.45 billion
CAGR (%) 17.27%

A concise framing of the evolving compound management landscape emphasizing technological, material, and operational pressures reshaping laboratory workflows

The compound management landscape sits at the intersection of high-throughput science, precision handling, and increasingly complex supply chain dynamics. Recent technological advances in automation, sample integrity monitoring, and digital inventory control have redefined expectations for accuracy, speed, and traceability across research organizations and commercial R&D. At the same time, shifts in therapeutic modalities toward biologics and cell and gene therapies have introduced new material handling requirements that challenge legacy platforms and demand purpose-built solutions.

Consequently, leaders must reconcile the need for robust, compliant compound custody with pressures to increase throughput and lower operational risk. This introduction synthesizes the forces reshaping compound management, clarifies where value is being created, and frames the strategic questions organizational leaders should prioritize. By establishing a shared baseline, decision-makers can evaluate technology investments, partnerships, and process redesigns with greater confidence and align compound handling capabilities to broader scientific and regulatory objectives.

How automation, biologics complexity, and data-driven interoperability are redefining compound management as a strategic laboratory capability

The landscape for compound management is undergoing transformative shifts driven by converging technological and scientific trends. Automation is maturing beyond mechanization into integrated workflows where robotics, environmental controls, and laboratory information management systems operate as a synchronized whole. This integration reduces manual touchpoints and error rates while enabling scalable sample throughput, yet it also increases the importance of systems interoperability and vendor collaboration. Simultaneously, the rise of complex biologics, gene therapies, and cell-based products imposes new storage, handling, and traceability requirements that legacy small-molecule-focused systems were not designed to satisfy.

In parallel, data-centric approaches are changing how organizations manage compound inventories. Advanced analytics and predictive maintenance improve uptime and reduce reagent waste, and digital audit trails enhance regulatory readiness. Moreover, partnerships between instrument manufacturers and software providers are accelerating the pace at which laboratories can adopt modular, upgradeable systems. Taken together, these shifts mean that compound management is no longer a back-office function; it is a strategic capability that underpins faster, safer, and more cost-effective research pipelines.

Operational and procurement responses to tariff shifts that are reshaping supplier strategies, inventory practices, and international collaboration in laboratories

Tariff dynamics introduced in 2025 have created tangible pressures across procurement, contract operations, and cross-border research collaborations. Elevated duties on specific laboratory equipment, consumables, and chemical imports have prompted many organizations to re-evaluate supplier portfolios and renegotiate contracts to preserve continuity of operations. As a result, procurement teams are working more closely with scientific leads to prioritize critical items for stockpiling, explore alternative suppliers, and qualify regional distributors to mitigate single-source exposure.

At the operational level, some laboratories have adjusted maintenance and calibration schedules to optimize the lifecycle of existing instruments and avoid immediate capital replacement during periods of higher import costs. In addition, greater emphasis is being placed on localization of critical supplies and on building strategic inventory buffers for reagents and consumables. International collaborations face added administrative burdens as customs classifications and compliance checks have increased lead times. In response, institutions are strengthening supply chain governance, enhancing demand forecasting practices, and pursuing contractual terms that share tariff risk between buyers and suppliers to sustain research continuity.

Deep segmentation-driven insights that illuminate distinct requirements across end users, compound types, applications, and automation levels to guide strategic product and service alignment

Segmentation insights reveal differentiated needs and adoption patterns that should guide product development, service models, and go-to-market approaches. When viewed through the lens of end users, academic and research institutions typically prioritize flexibility, cost-effectiveness, and open integration with diverse instrument fleets, whereas pharmaceutical companies demand validated, scalable systems with rigorous compliance features and long-term service commitments. Biotech companies often seek modular solutions that can accommodate rapid pivots in project scope, while contract research organizations focus on high-throughput capacity and standardized workflows to serve multiple clients. Government and regulatory agencies emphasize chain-of-custody and long-term archival integrity for samples used in surveillance and public health research.

Analyzing compound type highlights further nuances: small molecules generally benefit from established, high-density storage and automated retrieval systems, while biologics require specialized temperature control and contamination prevention; within biologics, cell therapy products, gene therapy products, monoclonal antibodies, recombinant proteins, and vaccines each present unique handling and regulatory demands that influence container formats, cold chain protocols, and validation pathways. Application-based segmentation shows that use cases such as agrochemicals and material science have different throughput and environmental tolerance requirements compared with drug discovery activities; within drug discovery, discrete workflows like hit identification, lead optimization, preclinical research, and target validation impose specific sampling cadence, aliquot sizing, and integrity monitoring needs. Finally, automation level differentiates buyer readiness: organizations opting for fully automated systems invest in end-to-end digital workflows and higher upfront capital for long-term efficiency, while manual and semi-automated systems remain prevalent where flexibility, lower capital expenditure, or unique sample types preclude full automation. Understanding these intersecting segments enables vendors and users to align solution features, service levels, and pricing strategies to real operational requirements.

How regional scientific ecosystems and regulatory environments influence compound management priorities, support models, and adoption of automation across global markets

Regional dynamics shape how organizations prioritize investments, partnerships, and operational resilience in compound management. In the Americas, a concentration of large pharmaceutical R&D hubs and mature biotech ecosystems drives demand for high-throughput, validated systems and service models that support regulated development. This region also features a strong aftermarket for integration services and localized support networks, encouraging vendors to offer long-term service agreements and customization options. Europe, the Middle East & Africa presents a diverse landscape where multinationals operate alongside national research institutes and an emerging biotech sector; regulatory harmonization across parts of Europe contrasts with localized procurement rules elsewhere, shaping adoption curves for automation and advanced inventory systems. In this region, interest in compliance-ready, modular solutions is pronounced given the need to balance cross-border collaboration with local regulatory constraints.

Asia-Pacific remains characterized by rapid capacity expansion, significant investment in translational and clinical research, and energetic growth of biotech startups that often demand flexible, scalable compound management solutions. The supply chain footprint in this region also fosters manufacturing and component sourcing opportunities, which can lower lead times for certain equipment. Across all regions, variations in labor costs, regulatory complexity, and infrastructure maturity influence the choice between fully automated and semi-automated or manual approaches, and they create opportunities for differentiated service offerings such as remote diagnostics, regional spare parts inventories, and localized validation support.

Competitive dynamics and partnership trends revealing how hardware-software-service integration and application-focused innovation are shaping vendor differentiation and customer retention

Key company insights focus on strategic positioning, partnership models, and the areas where competitive differentiation is emerging. Market leaders that pair robust hardware portfolios with scalable software platforms and proven service delivery are best positioned to capture enterprise-level programs requiring long-term validation and uptime guarantees. Conversely, emerging vendors find traction by offering modular, upgradeable architectures that lower the barrier to automation for midsized laboratories and by emphasizing interoperability through open APIs that facilitate integration with laboratory information management systems. Strategic partnerships between instrument manufacturers, software providers, and third-party service organizations are increasingly common as companies seek to deliver end-to-end value propositions covering installation, validation, maintenance, and data management.

Additionally, some firms are investing in application-specific solutions that address the unique demands of biologics and cell and gene therapies, including temperature-controlled logistics and contamination control innovations. Service differentiation is also notable: providers that can offer rapid on-site support, predictive maintenance remotely enabled by IoT sensors, and tailored training for in-house technical staff tend to reduce downtime and build stronger customer retention. Finally, companies that demonstrate a commitment to sustainability through energy-efficient storage systems and consumable reduction initiatives are resonating with institutional buyers seeking to meet environmental and governance objectives.

Actionable strategic priorities for executives to strengthen interoperability, supply resilience, and data-driven operations in compound management environments

Industry leaders should take decisive actions to align compound management capabilities with scientific strategy and operational resilience. First, executives should prioritize interoperability and modularity when evaluating new equipment, ensuring that investments can be scaled or repurposed as scientific priorities change. Second, cross-functional governance structures that include procurement, scientific operations, quality, and IT should be established to streamline supplier qualification, manage tariff and supply chain risk, and enforce data integrity standards. Third, organizations should pilot data-rich initiatives that use analytics and IoT-enabled diagnostics to reduce unplanned downtime and optimize reagent utilization, thereby simultaneously improving throughput and lowering operational risk.

Moreover, leaders ought to assess their portfolio of suppliers and service agreements through scenario planning that accounts for regional sourcing variability and potential policy shifts. Investing in staff training and in-house validation capabilities will reduce dependency on external service providers and accelerate time-to-experiment. Finally, sustainability and compliance should be elevated as strategic imperatives; adopting energy-efficient storage technologies, reducing single-use plastic consumption where feasible, and documenting chain-of-custody practices will both reduce cost pressure over time and align the organization with evolving stakeholder expectations.

A rigorous mixed-methods approach combining practitioner interviews, technical literature review, and expert validation to derive practical operational insights and strategic recommendations

The research methodology underpinning this executive summary combined a structured review of primary and secondary inputs with expert validation to ensure relevance and practical applicability. Primary sources included interviews with laboratory managers, procurement heads, and technical leads across academic, biotech, contract research, government, and pharmaceutical organizations to capture firsthand operational challenges and procurement behaviors. Secondary inputs encompassed vendor technical literature, regulatory guidance documents, and peer-reviewed publications that describe evolving handling requirements for small molecules and complex biologics, as well as white papers on automation and data integration best practices.

These inputs were synthesized using a thematic analysis approach to identify recurring pain points, adoption enablers, and value levers. Cross-validation with experienced technologists and supply chain specialists ensured that operational recommendations were grounded in real-world constraints and opportunities. Care was taken to anonymize sensitive contributor information, and all conclusions emphasize qualitative trends and actionable insights rather than quantitative market estimates, enabling leaders to apply findings directly to technology selection, process redesign, and vendor negotiations.

A forward-looking synthesis explaining why compound management is now a strategic enabler of research velocity, sample integrity, and regulatory readiness for R&D organizations

In conclusion, compound management has evolved from a largely transactional back-office function to a strategic capability that materially influences research velocity, data integrity, and regulatory readiness. Advancements in automation, the growing prominence of biologics and cell and gene therapies, and increasing emphasis on data-driven maintenance and inventory control are converging to raise the bar for system interoperability, environmental controls, and service reliability. Organizations that proactively align procurement, scientific operations, and IT functions will be better positioned to capture the productivity gains offered by modern compound management systems and to mitigate risks associated with supply chain volatility and regulatory scrutiny.

Moving forward, decision-makers should treat compound management as an integral component of their research platform strategy-investing in modular, validated systems where appropriate, strengthening supplier and regional risk management, and leveraging analytics to optimize uptime and reagent use. By doing so, laboratories and development organizations can improve throughput, safeguard sample integrity, and support the translational goals that drive scientific and commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven scheduling and predictive routing for automated compound storage retrieval workflows
  • 5.2. Adoption of robotic nanoliter liquid handling systems enabling high-density compound library management
  • 5.3. Implementation of blockchain-enabled chain of custody tracking across decentralized compound repositories
  • 5.4. Deployment of IoT-enabled temperature and humidity sensors for real-time compound stability monitoring
  • 5.5. Utilization of digital twin simulations to optimize freezer defrost cycles and sample integrity in compound management
  • 5.6. Transition to sustainable solvent-free cleaning and cryogenic storage methods in compound management facilities

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Compound Management Market, by End User

  • 8.1. Academic And Research Institutions
  • 8.2. Biotech Companies
  • 8.3. Contract Research Organizations
  • 8.4. Government And Regulatory Agencies
  • 8.5. Pharmaceutical Companies

9. Compound Management Market, by Compound Type

  • 9.1. Biologics
    • 9.1.1. Cell Therapy Products
    • 9.1.2. Gene Therapy Products
    • 9.1.3. Monoclonal Antibodies
    • 9.1.4. Recombinant Proteins
    • 9.1.5. Vaccines
  • 9.2. Nucleotides
  • 9.3. Peptides
  • 9.4. Small Molecules

10. Compound Management Market, by Application

  • 10.1. Agrochemicals
  • 10.2. Drug Discovery
    • 10.2.1. Hit Identification
    • 10.2.2. Lead Optimization
    • 10.2.3. Preclinical Research
    • 10.2.4. Target Validation
  • 10.3. Material Science
  • 10.4. Specialty Chemicals

11. Compound Management Market, by Automation Level

  • 11.1. Fully Automated Systems
  • 11.2. Manual Systems
  • 11.3. Semi Automated Systems

12. Compound Management Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Compound Management Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Compound Management Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Thermo Fisher Scientific Inc.
    • 15.3.2. Danaher Corporation
    • 15.3.3. Agilent Technologies, Inc.
    • 15.3.4. PerkinElmer, Inc.
    • 15.3.5. Tecan Group Ltd.
    • 15.3.6. Hamilton Bonaduz AG
    • 15.3.7. Brooks Automation, Inc.
    • 15.3.8. Chemspeed Technologies GmbH
    • 15.3.9. Hudson Robotics, Inc.
    • 15.3.10. Analytik Jena AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. COMPOUND MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. COMPOUND MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. COMPOUND MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GOVERNMENT AND REGULATORY AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GOVERNMENT AND REGULATORY AGENCIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GOVERNMENT AND REGULATORY AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GOVERNMENT AND REGULATORY AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GOVERNMENT AND REGULATORY AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GOVERNMENT AND REGULATORY AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CELL THERAPY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CELL THERAPY PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CELL THERAPY PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CELL THERAPY PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CELL THERAPY PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CELL THERAPY PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GENE THERAPY PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GENE THERAPY PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GENE THERAPY PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GENE THERAPY PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY NUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY NUCLEOTIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY NUCLEOTIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY NUCLEOTIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY NUCLEOTIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY NUCLEOTIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PEPTIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PEPTIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PEPTIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PEPTIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PEPTIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SMALL MOLECULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SMALL MOLECULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AGROCHEMICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AGROCHEMICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AGROCHEMICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AGROCHEMICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AGROCHEMICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AGROCHEMICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY HIT IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY HIT IDENTIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY HIT IDENTIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY HIT IDENTIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY HIT IDENTIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY HIT IDENTIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY TARGET VALIDATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY TARGET VALIDATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY TARGET VALIDATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY TARGET VALIDATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MATERIAL SCIENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MATERIAL SCIENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MATERIAL SCIENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MATERIAL SCIENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MATERIAL SCIENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MATERIAL SCIENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SPECIALTY CHEMICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SPECIALTY CHEMICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SPECIALTY CHEMICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SPECIALTY CHEMICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SPECIALTY CHEMICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SPECIALTY CHEMICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 297. GCC COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GCC COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GCC COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. GCC COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. GCC COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. GCC COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. GCC COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 304. GCC COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 305. GCC COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. GCC COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. GCC COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 308. GCC COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 309. GCC COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 310. GCC COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPEAN UNION